Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Notoginsenoside R2

Copy Product Info
🥰Excellent
Catalog No. T6S1587Cas No. 80418-25-3
Alias Ginsenoside Ng-R2, 20(S)-Notoginsenoside R2

Notoginsenoside R2 (20(S)-Notoginsenoside R2) has neuroprotection against 6-OHDA-induced neurotoxicity, is associated with Notoginsenoside R2-mediated P90RSK and Nrf2 activation through MEK1/2-ERK1/2 pathways.

Notoginsenoside R2

Notoginsenoside R2

Copy Product Info
🥰Excellent
Purity: 99.92%
Catalog No. T6S1587Alias Ginsenoside Ng-R2, 20(S)-Notoginsenoside R2Cas No. 80418-25-3
Notoginsenoside R2 (20(S)-Notoginsenoside R2) has neuroprotection against 6-OHDA-induced neurotoxicity, is associated with Notoginsenoside R2-mediated P90RSK and Nrf2 activation through MEK1/2-ERK1/2 pathways.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$33In StockIn Stock
5 mg$70In StockIn Stock
10 mg$100In StockIn Stock
25 mg$163In StockIn Stock
50 mg$239In StockIn Stock
100 mg$356In StockIn Stock
1 mL x 10 mM (in DMSO)$120In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.92%
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Notoginsenoside R2 AI Summary
Notoginsenoside R2 exhibits significant bioactivity as an inhibitor of cell proliferation in both human U251 and rat C6 cells. In human U251 cells, it demonstrated a cell viability inhibition activity of 107.8% at a concentration of 100 µM after 72 hours, as assessed by the sulforhodamine B assay. Additionally, in rat C6 cells, the compound inhibited cell viability by 59.31% under identical conditions..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Notoginsenoside R2 (20(S)-Notoginsenoside R2) has neuroprotection against 6-OHDA-induced neurotoxicity, is associated with Notoginsenoside R2-mediated P90RSK and Nrf2 activation through MEK1/2-ERK1/2 pathways.
SynonymsGinsenoside Ng-R2, 20(S)-Notoginsenoside R2
Chemical Properties
Molecular Weight770.99
FormulaC41H70O13
Cas No.80418-25-3
Smiles[H][C@@]1(CC[C@]2(C)[C@]1([H])[C@H](O)C[C@]1([H])[C@@]3(C)CC[C@H](O)C(C)(C)[C@]3([H])[C@H](C[C@@]21C)O[C@]1([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@]1([H])OC[C@@H](O)[C@H](O)[C@H]1O)[C@@](C)(O)CCC=C(C)C
Relative Density.1.314g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 25 mg/mL (32.43 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (2.59 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.2970 mL6.4852 mL12.9703 mL64.8517 mL
5 mM0.2594 mL1.2970 mL2.5941 mL12.9703 mL
10 mM0.1297 mL0.6485 mL1.2970 mL6.4852 mL
20 mM0.0649 mL0.3243 mL0.6485 mL3.2426 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Notoginsenoside R2 | purchase Notoginsenoside R2 | Notoginsenoside R2 cost | order Notoginsenoside R2 | Notoginsenoside R2 chemical structure | Notoginsenoside R2 formula | Notoginsenoside R2 molecular weight